The Food and Drug Administration (FDA) announced approval for two new generic drugs for cats in January.

Approved were generic marbofloxacin tablets from two companies, Felix Pharmaceuticals and ZyVet Animal Health. The agency approved the tablets for use in dogs and cats to treat infections associated with bacteria susceptible to marbofloxacin.

The agency also approved generic dexmedetomidine hydrochloride from ZyVet Animal Health for use in dogs and cats as a sedative and analgesic to facilitate clinical examinations, clinical procedures, minor surgical procedures, and minor dental procedures. Dexmedetomidine hydrochloride is also indicated for use as a preanesthetic to general anesthesia in cats and dogs.

Read more about these and other FDA recently approved animal drugs.